Alembic Pharmaceuticals Other Announcement
Alembic Pharmaceuticals requested physical shareholders to update KYC and nomination details with MUFG Intime India. Compliance ensures timely dividend credits and prevents withholding per SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Alembic Pharmaceuticals requested physical shareholders to update KYC and nomination details with MUFG Intime India. Compliance ensures timely dividend credits and prevents withholding per SEBI regulations.
Alembic Pharmaceuticals submitted its Annual Secretarial Compliance Report for the year ended March 2026. The auditor confirmed full regulatory compliance with no deviations or fines reported.
Alembic Pharmaceuticals Ltd submitted an annual compliance certificate from a Chartered Accountant for the CRA Family Trust. The certificate confirms compliance with the SEBI Exemption Order dated September 30, 2020, for the financial year ended March 31, 2026.